PIGHI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 696
EU - Europa 490
AS - Asia 206
OC - Oceania 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.397
Nazione #
US - Stati Uniti d'America 693
CN - Cina 109
IT - Italia 97
IE - Irlanda 83
RU - Federazione Russa 80
FR - Francia 77
SG - Singapore 68
SE - Svezia 57
DE - Germania 40
FI - Finlandia 26
KR - Corea 12
GB - Regno Unito 9
BE - Belgio 5
HK - Hong Kong 5
VN - Vietnam 5
AT - Austria 4
AU - Australia 3
ES - Italia 3
IR - Iran 3
CA - Canada 2
NL - Olanda 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
ID - Indonesia 1
IS - Islanda 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
Totale 1.397
Città #
Chandler 244
Ashburn 103
Dublin 80
Singapore 39
Beijing 38
Lawrence 22
Princeton 22
Seattle 22
Redmond 20
Verona 20
Sindelfingen 18
Helsinki 17
Wilmington 16
Seoul 12
Lappeenranta 8
Ann Arbor 7
Milan 7
Shenzhen 7
Pescantina 6
Ancona 5
Bonndorf 5
Brussels 5
Guangzhou 5
Hong Kong 5
New York 5
Rome 5
Southend 5
Dallas 4
Peschiera del Garda 4
Tappahannock 4
Tianjin 4
Vienna 4
Washington 4
Woodbridge 4
Xi'an 4
Zhengzhou 4
Dongguan 3
Fairfield 3
Frankfurt am Main 3
Levallois-perret 3
Los Angeles 3
Neumünster 3
Norwalk 3
Paris 3
Taizhou 3
Treviso 3
Amsterdam 2
Cambridge 2
Chiuppano 2
Dong Ket 2
Durham 2
Fuzhou 2
Krakow 2
Madrid 2
San Francisco 2
San Giovanni Lupatoto 2
Trevenzuolo 2
Turin 2
Bentivoglio 1
Boardman 1
Bologna 1
Bratislava 1
Brescia 1
Brisbane 1
Bucharest 1
Buffalo 1
Cairo 1
Canberra 1
Cassano delle Murge 1
Catania 1
Changsha 1
Chicago 1
Clonee 1
Dhaka 1
Dubai 1
Edinburgh 1
Fremont 1
Gunzenhausen 1
Haikou 1
Hangzhou 1
Hebei 1
Ho Chi Minh City 1
Johnstown 1
Laurel 1
London 1
Lviv 1
Manila 1
Marino 1
Mataró 1
Melbourne 1
Miami 1
Montignoso 1
Montréal 1
Negrar 1
Newark 1
Niagara Falls 1
Novokuznetsk 1
Nuremberg 1
Padova 1
Palermo 1
Totale 880
Nome #
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers 71
Clinical assessment of FREND COVID-19 Ag test in an unselected population referred for routine SARS-CoV-2 testing 61
Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit 60
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters 60
Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers 57
Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA 56
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals 56
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination 54
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series 49
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay 49
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay 48
Variation of Forehead Temperature during Routine Working Shift in Hospital Laboratory Personnel: Implications for SARS-CoV-2 Screening 48
Evaluation of indoor hospital acclimatization of body temperature before COVID-19 fever screening 45
Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster 45
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals 43
Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination 40
Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay 37
SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load 36
Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers 35
Serum C reactive protein predicts humoral response after BNT162b2 booster administration 33
Humoral response post-BNT162b2 single booster in pre-vaccination baseline SARS-CoV-2 seronegative and seropositive subjects 30
Effect of syringe underfilling on the quality of venous blood gas analysis 27
Association between viral load and positivization time of a SARS-CoV-2 rapid antigen test in routine nasopharyngeal specimens 25
Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept 24
Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers 24
Monoclonal gammopathy in SARS-CoV-2 infection 23
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity 22
Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i 18
Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassay 18
Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers 18
Correlation Between Time to Positive Result of SARS-CoV-2 Rapid Antigen Self-Test and Viral Antigen Concentration 17
Cellular immunity against SARS-CoV-2 depends on the serological status 17
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test 16
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection? 16
Impact of the COVID-19 pandemic on the volume of laboratory testing 15
Variation of Total Anti-SARS-CoV-2 Antibodies After Primary BNT162b2 Vaccination and Homologous Booster 14
Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine: a proof-of-concept study 13
Monitoring humoral and cellular immunity over 6 months after mRNA-based bivalent COVID-19 vaccine administration 13
Reliability of a single-nostril nasopharyngeal swab for diagnosing SARS-CoV-2 infection 13
Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing 12
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay 12
Accuracy of screening for hemolysis in plasma samples using a commercial urine dipstick 12
Impact of an air bubble within the syringe on test results obtained with a modern blood gas analyzer 11
Clinical assessment of Ortho VITROS SARS-CoV-2 antigen chemiluminescence immunoassay 10
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2 10
Can cellular and humoral immunity predict response to BNT162b2 bivalent booster? 10
Effect of exogenous lipids contamination on blood gas analysis 10
The incremental impact of comorbidities in COVID-19-related deaths compared to patients dying from cancer or cardiovascular disease 9
Humoral response is enhanced after ipsilateral double intramuscular injection of BNT162b2 COVID-19 vaccine 9
Vaccination time does not influence total anti-SARS-CoV-2 antibodies response 8
Preanalytical Impact of Incomplete K2EDTA Blood Tube Filling in Molecular Biology Testing 8
Update on Patient Self-Testing with Portable and Wearable Devices: Advantages and Limitations 7
Is mixing of blood gas syringes after collection really necessary? 6
Generative artificial intelligence (AI) for reporting the performance of laboratory biomarkers: not ready for prime time 3
Urine dipstick for screening plasma glucose and bilirubin in low resource settings: a proof-of-concept study 3
Totale 1.486
Categoria #
all - tutte 8.726
article - articoli 8.726
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.452


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 2 3 2 17
2021/2022205 29 37 7 8 10 4 4 6 14 8 26 52
2022/2023621 36 51 58 116 31 126 23 54 63 9 29 25
2023/2024433 19 30 29 45 66 48 43 71 4 25 38 15
2024/2025203 65 84 54 0 0 0 0 0 0 0 0 0
Totale 1.486